Claude Science

2026-10-21

RESEARCH · 1 SOURCE · The Decoder

Anthropic’s Claude Science designed protein binders targeting scorpion neurotoxins

Anthropic’s Claude, run inside the Claude Science research environment, autonomously generated 318,484 designs for protein binders against five neurotoxins from four scorpion species and—after additional human steering—211 designs were tested in the lab; 17 met binding criteria and two bound very tightly to Cn2 (a Mexican scorpion toxin). Two independent labs reproduced the results and external experts called it a promising first step, but the designs have not yet been shown to neutralize venom in animals or humans.

8.0

2026-10-20

COMPANIES · 1 SOURCE · Anthropic

Anthropic rolls out a wide suite of Claude features, connectors and partnerships (2025–2026)

Anthropic announced multiple product updates and launches for its Claude AI platform across 2025–2026, including the Anthropic Economic Index connector, Claude Science (a researcher workbench), Claude Design, Claude Tag, Claude for Teachers, Claude for Small Business, healthcare and nonprofit offerings, expanded plugins and integrations, a compute partnership with SpaceX, and availability of Sonnet 4.5/Haiku 4.5/Opus 4.1 in Microsoft Foundry. These releases add domain-specific apps, connectors, higher usage limits, and enterprise integrations.

7.0

2026-10-09

RESEARCH · 1 SOURCE · The Decoder

Anthropic’s Claude Science produces first complete ultraviolet map of the sky

Anthropic’s Claude Science coordinated AI agents to download, calibrate, merge and inpaint data from multiple space missions to produce the first complete ultraviolet map of the sky; tests showed inpainted predictions averaged about 10% deviation from measurements. The map is being released as teaching material and highlights how AI can automate tedious data-integration tasks researchers often defer.

6.0

2026-09-22

COMPANIES · 1 SOURCE · The Decoder

Anthropic building San Francisco-area biology lab where Claude will guide robots

Anthropic is establishing a biology lab near San Francisco to run physical drug experiments with AI guidance; the company plans for Claude to direct robots through experiments using tools such as Claude Science and the Model Hardware Standard, with human oversight retained. The move follows Anthropic's acquisition of Coefficient Bio (about $400 million) and addition of Novartis CEO Vas Narasimhan to its board; Anthropic says it will not run clinical trials for now.

7.0

2026-09-18

MODELS · 4 SOURCES · Anthropic · TechCrunch AI · The Verge AI · The Decoder

Anthropic releases Claude Opus 5 — lower-cost model claiming near‑frontier performance

Anthropic announced Claude Opus 5, a new model positioned as a cost‑efficient successor to Opus 4.8 and the new default on Claude Max (and the strongest on Claude Pro). Anthropic says Opus 5 matches or exceeds prior models on many coding, knowledge‑work and scientific benchmarks (Frontier‑Bench, GDPval‑AA, CursorBench, ARC‑AGI, Zapier AutomationBench, OSWorld) at lower cost per task while remaining behind Mythos 5 on security and biology frontier tasks; the company also reports improved alignment and safety in pre‑deployment audits and links a System Card for more details.

8.0

2026-09-16

RESEARCH · 1 SOURCE · Anthropic

Anthropic opens 10,000 Claude subscriptions for scientists and expands AI for Science credits

Anthropic is opening 10,000 seats to let verified academic and nonprofit labs access Claude subscriptions free or at discounted premium rates ($15/month with 5× usage) for one year, and plans to extend the program. The company is also expanding its AI for Science credits (up to $50,000 per project), limiting biology/chemistry to Opus-class models while blocking professional bio queries on Fable models, working with the US government to pilot Mythos-class access, reporting three July 30 incidents of unauthorized system access under investigation with METR, and previewing the Model Hardware Standard (MHS) to select labs and manufacturers.

8.0

2026-08-31

MODELS · 1 SOURCE · NVIDIA Developer

Run NVIDIA BioNeMo NIM Microservices for Protein Structure Prediction in Claude Science

NVIDIA Developer published guidance on running BioNeMo NIM microservices for protein structure prediction inside Claude Science, illustrating how NVIDIA’s model microservices can be invoked within an agentic research workflow. The article frames this integration in the context of agentic AI that can read papers, propose hypotheses, call models, and prioritize experiments.

6.0